Literature DB >> 6640008

A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics.

B Bogerts, J Häntsch, M Herzer.   

Abstract

A quantitative study of the melanin-containing dopaminergic neurons of the nigrostriatal system (A 9) and of the mesolimbic system (A 10) was carried out on Nissl-stained serial sections of nine normal brains, six age-matched brains of schizophrenics, five brains of paralysis agitans, and six brains of postencephalitic parkinsonism. By contrast with most laboratory animals the A 10 cell group is not well developed in the human brain. Both in Parkinson's disease with a known hypoactivity of dopamine neurons and in schizophrenia with a postulated hyperfunction of these systems, pathological alterations of the dopamine cell groups can be observed. In paralysis agitans the nigrostriatal and the mesolimbic cell groups exhibit a significant loss of neurons, while the remaining mesolimbic cells appear to be in better condition. In the postencephalitic parkinsonism both systems have almost completely disappeared with a significant loss of nerve and glial cells. In schizophrenia there is a significant decrease in the volume of the nigrostriatal area. Here the mean volume of the glial nuclei is reduced, whereas the mean volume of the nerve cells is diminished in the mesolimbic part.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6640008

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  39 in total

1.  Selective loss of nigral neurons in Alzheimer's disease: a morphometric study.

Authors:  T Uchihara; H Kondo; K Kosaka; H Tsukagoshi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Selective loss of nigral neurons in Pick's disease: a morphometric study.

Authors:  T Uchihara; K Tsuchiya; K Kosaka
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex.

Authors:  S M Clinton; I L Sucharski; J M Finlay
Journal:  Psychopharmacology (Berl)       Date:  2005-11-24       Impact factor: 4.530

Review 4.  Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs).

Authors:  Haneul Noh; Zhicheng Shao; Joseph T Coyle; Sangmi Chung
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-28       Impact factor: 5.187

Review 5.  Essential aspects of the research problem in schizophrenia.

Authors:  S R Hirsch
Journal:  J R Soc Med       Date:  1988-12       Impact factor: 5.344

Review 6.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

Review 7.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

Review 8.  Metabolic hormones, dopamine circuits, and feeding.

Authors:  Nandakumar S Narayanan; Douglas J Guarnieri; Ralph J DiLeone
Journal:  Front Neuroendocrinol       Date:  2009-10-28       Impact factor: 8.606

9.  The progression of idiopathic Parkinson's disease is not explained by age-related changes. Clinical and pathological comparisons with post-encephalitic parkinsonian syndrome.

Authors:  W R Gibb; A J Lees
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

10.  The Vulnerable Ventral Tegmental Area in Parkinson's Disease.

Authors:  Stephanie L Alberico; Martin D Cassell; Nandakumar S Narayanan
Journal:  Basal Ganglia       Date:  2015-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.